Drug resistance mutations after the first 12 months on antiretroviral therapy and determinants of virological failure in Rwanda
Abstract
To evaluate HIV drug resistance (HIVDR) and determinants of virological failure in a large cohort of patients receiving first‐line tenofovir‐based antiretroviral therapy (ART) regimens.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Jun 13, 2016
- Source ID
- 10.1111/tmi.12717
Entities
People
- Augustin Mulindabigwi
- Catherine Kirk
- David J. Riedel
- Dieudone Sebuhoro
- Jamie I. Forrest
- Jean Claude Uwimbabazi
- Jean D'amour Ndahimana
- Jules Mugabo
- Linda L. Jagodzinski
- Marthe Kubwimana
- Muhayimpundu Ribakare
- Mutagoma Mwumvaneza
- Robert R. Redfield
- Sabin Nsanzimana
- Sheila A. Peel
- Steve Kanters
Organizations
- Henry M. Jackson Foundation for the Advancement of Military Medicine
- Institute of Human Virology
- Partners In Health
- Swiss Tropical and Public Health Institute
- United States Department of Defense
- University of British Columbia
- Walter Reed Army Institute of Research
- World Health Organization